New cancer pill tested in humans – but trial halted early

NCT ID NCT05605119

Terminated Disease control Sponsor: Aurigene Discovery Technologies Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tested an oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had not responded to prior treatments. The study aimed to find a safe dose and check how the drug moves through the body. However, the trial was terminated, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AUR105 (oral drug)
What this could lead to: If successful, this could point toward a new treatment option for advanced cancers that have stopped responding to other therapies.
What could go wrong: This is a very early, small Phase 1 trial (only 17 participants) that was terminated, so results are limited. The drug may not prove effective or safe in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma neoplasm non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HODGKIN LYMPHOMA NON-HODGKIN LYMPHOMA SOLID TUMOR, ADULT

Contacts and locations

Locations

ALL India Institute of medical Scieneces

New Delhi, New Delhi, 110029, India
All India Institute of Medical Sciences

Bhubaneswar, Odisha, 751019, India
HCG City Cancer Center

Vijayawada, Andhra Pradesh, 520002, India
IMS&SUM Hospital

Bhubaneswar, Bhubaneswar, 751003, India
Kailash Cancer Hospital and Research Centre

Vadodara, Gujarat, 391760, India
Krupamayi Hospital

Aurangabad, Maharashtra, 431001, India
Moraya Multi-Speciality Hospital

Pune, Maharasthra, 411033, India
Omega Hospitals

Visakhapatnam, Andhra Pradesh, 530040, India
Sparsh Hospital and Critical Care

Bhubaneswar, Odisha, 751007, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.